Dana Ullman's Homeopathy Studies Thread

Badly Shaved Monkey

Anti-homeopathy illuminati member
Joined
Feb 5, 2004
Messages
5,363
Here is a thread where homeopathic research studies can be posted.

To qualify for entry they need to have their full bibliographic citation and a source where their full text may be obtained.

Any commentary must be based on having read the full text. Those choosing to commentate should be aware that an appropriate test may be made to check their veracity in this matter.
 
Here's the last study that Dana posted today on the other thread:

Effect of Homeopathic Treatment on Gene Expression in Copenhagen Rat Tumor Tissues
Rajesh L. Thangapazham, N. V. Rajeshkumar, Anuj Sharma, Jim Warren, Anoop K. Singh, John A. Ives, Jaya P. Gaddipati, Radha K. Maheshwari and Wayne B. Jonas
Integr Cancer Ther 2006; 5; 350
DOI: 10.1177/1534735406294226

Complete PDF text here
 
I've had a preliminary look at this. I have some queries.

Firstly, as active homeopathy preparations, they selected 4 different supposedly useful prostate cancer remedies out of 8 available. However, we are not told why these are thought to be useful in prostate cancer - do they help obviate side-effects of orthodox therapy, or do they help some other symptom, or are they meant to cure the problem? There seems to be little information on this and no explanation has been given as to why these 4 preparations were chosen, other than that they are claimes to treat cancer in clinics in India. (and their reference to a study in India is not available at the web address stated - reference 9)

Then, all 4 preparations are all used on the same individual animal - there is no attempt to see the effects of individual remedies - If the rat is in the homeopathy group, it gets all 4 remedies cycled on different days. I must ask why? If the authors wished to "examine potential mechanisms for action" as they said they did, why give the rats a cocktail of therapy? How will this help reveal a mode of action for homeopathy?

Secondly, controls were variously described as "tap water" or as "distilled water" (serially diluted). Active drug was either bought from a commercial company (3 remedies) or in one case made up by a selected homeopathic pharmacy. The source of control water is not clear, and there is no attempt to find a control that is identical to the appropriate homeopathic carrier, and therefore I wonder if there may have been other chemical/biological differences between controls and homeopathy. Ideally one should use controls manufactured at the same time as homeopathy preps and using identical methods.

Crucially, there is no attempt to use as controls any other homeopathic preparations that would be expected to have absolutely no effect on prostate cancer - for instance using a preparation that is good for say morning sickness, or headaches.

The lack of appropriate controls, and control solutions makes me suspect we are not seeing a difference that can be attributed to the anticancer effects of the homeopathic preparations but to something else.

Thirdly, there is no attempt to look for any dose-related (dilution) effect. As we all know, a 1000c preparation of carcinosin is very potent stuff! Why did the researchers not use a continuum of dilutions, say 10x, 1c, 50c, 100c, 500c and 1000c and assess the effects? They could have done this with their in-vitro study, easily. An ideal opportunity to check for this central tenet of the law of dilutions has passed them by.

I think the trial was well conducted in the laboratory sense, but with very poor methodology. I doubt that the differences seen can be described as attributable to homeopathy alone, and suspect something else might be confounding the results.

Finally, a note from the authors:
"Given a lack of mechanism to explain our findings, interpretation of these data should be done cautiously". They call for other studies to replicate their findings.

They also say in their introduction "There have been no high quality studies of homeopathy on the treatment of cancer".
(Are you reading this, James Gully?) Sadly, this trial doesn't seem to have bucked the trend.
 
Last edited:
The study by Jonas was kicked around a bit before, here. Reading through the paper, there are several ways any break in blinding would lead to differences in assessment that could easily account for the differences. The assessment as to whether tumor was present, for example. And I suspect it may be possible to detect the difference between tap water and distilled water (I certainly can with my tap water), leading to a loss of blinding for those involved in the study.

It also wasn't clear from the description when/why they killed the animals and if all were killed, so the significance of time to killing or the tumor weight at time of killing is uncertain.

Yet another example of the 'best' that they can come up with - small, often trivial, rarely replicated effects.

Linda
 
Also, we seem to have been vouchsafed no comment whatsoever regarding Dana's pride and joy study, the one he promised us would shake our world-view to its foundations when it was published, and which he returned to the forum to trumpet about when it finally came out. Rustum Roy's stuff, of course (Sunday name "Rao et al. 2007")

I will be curious which ones of you will be smart enough to formally apologize for your antagonism to homeopathy, though many flat-earthers died believing in their silly beliefs.

I had previously alerted you to some forthcoming research on homeopathy, and it has now been published. Poor Ben Goldacre has decried that he doesn't have access to the journal ("Homeopathy") that is published by Elsevier, but heck, such is the catch 22 when skeptics insist that we publish in peer-review journals and then bemoan the fact that they cannot access them without going to a proper library to read them.

<snip irrelevant argument from authority about some other writings of one of the featured authors>

http://www.sciencedirect.com/science/journal/14754916
--the table of contents of a special issue on "the memory of water" in the journal, HOMEOPATHY, published by Elsevier.


Well, what a shame. By the time Dana appeared with that, we'd all got hold of the full-text article and had not only found it quite shockingly incompetent, but been inspired to submit a letter to the editor of the journal to that effect, which has been accepted for publication.

I think my next comment, after Dana had ignored our feedback, is worth repeating here.

James/Dana, you still haven't offered any comment on the critique we offered of Rustum Roy's UV spectroscopy publication. You accused us of having no "scientific chops". That post contains a pukka letter to the editor of the journal, signed by 3 PhDs and a nearly-PhD, demolishing Roy's presented data. We asked for your reaction. So far, none has been forthcoming.

You see, every time we look in detail at a publication which is being lauded by the homoeopathic community, in an area where we have particular expertise, we find the same thing. It's rubbish. Now not everyone is an expert in every aspect of science that has been used to prop up the mouldering corpse that is homoeopathy, so not everyone can critique every paper at the drop of a hat. But every time we assemble expertise in the right area, in this case UV spectroscopy, we find something so incompetently executed and presented that the possibility of deliberate misdirection or even fraud presents itself rather forcefully. Not one paper have I ever seen where the relevant experts were left saying, well, that's interesting....

Grow up, why don't you?

Rolfe.


That's the point. Every time you or some other homoeopath (like Xanta of blessed memory) comes up with a prize citation, we wearily plough through it and find the same old same old. Bad design, bad execution, conclusions not supported by evidence, cherrypicked data and so on.

You promptly drop it like a hot potato and find something even more obscure to crow about. Until that's demolished in its turn. (Indeed, you don't even drop the things that have been discredited, you just stop referring to them in present company - I note you were still praising Roy's work in the Grauniad blog.) Most of the time you don't even seem to have read the papers you're promoting, and I have to say I think even if you did you'd be struggling to understand what they were saying - just like you didn't realise that a reference to "ICU" meant the patients were in an intensive care unit until BSM pointed it out to you.

So are you going to make this game worth our while and actually present something with some substance to it, which you yourself have read in its entirety, fully comprehend, and are prepared to defend? Cos if not, well, it's all getting a bit tedious.

Rolfe.
 
Last edited:
Yes, I agree with Rolfe on that one, I'd really like to hear Dana's comments on the shipwreck that is Roy's paper. He was so full of himself when he told us about it.

We might even need to start another clock running on how long he is going to evade comment on poor old Professor Roy's paper.
 
The study by Jonas was kicked around a bit before, here. Linda
Good heavens!
:blush:
Someone give me some aricept, fast.

I commented on this paper in March, and couldn't even remember doing so.


(PS - I give a linky, so as to boost my Pharma-mole income)
 
Good heavens!
:blush:
Someone give me some aricept, fast.

I commented on this paper in March, and couldn't even remember doing so.


(PS - I give a linky, so as to boost my Pharma-mole income)

I wasn't going to say anything....

;)

Linda
 
What is interesting and unusual about THIS study was that only ONE homeopathic medicine was given, without individualization of treatment. The results of this trial surprised me, but this medicine is known to cause (and cure) thick tracheal secretions like those with advanced COPD.

I thought you wanted to reject all studies that weren't properly individualised. Please try to at least pretend that you are going to have a consistent set of principles. One might almost think that you just pull these judgements from your fundament to suit the need of the moment.

this medicine is known to cause (and cure) thick tracheal secretions like those with advanced COPD.

"known"? Please provide the objective evidence that such is the case. Even at its most generous reading this paper did not find a 'cure' of anything. This is like your general statement that Oscillinoccinum was "effective" against flu because one parameter in one study was marginally statistically significant with a lower bound on its confidence limit of 86 minutes reduction in the total length of the bout of flu.

I watched the DVD of Memento yesterday. The problems of dealing with someone suffering from anterograde amnesia reminded me very strongly of this discussion.

My previous reference to another trial also at the University of Vienna Hospital on patients with severe sepsis found a 50% reduced mortality rate in patients who were given an individually selected homeopathic medicine, as compared with those given a placebo. The only critique that was given to this trial was that people should avoid Vienna is the normal death rate for severe sepsis is 50%, even though the literature normally find that the death rate for this serious condition is between 40-70% (is this condition adequately beyond self-limiting?).

Small numbers. Unreliable data. Sepsis is such a heterogenous condition that small number studies are worthless except as pilots. You should be able to tell that fact simply by looking at the survival rates you reported yourself. If the range is 40-70% so there is no way that a small study could reliably report any change for better or worse in that rate. Let's await a replication with larger numbers.

A small but significant study of people with brain cancer was conducted in association with M.D. Anderson Cancer Center at the University of Texas (one of the most respected cancer research centers in the world), and it was published in the prestigious journal, International Journal of Oncology). Fifteen patient diagnosed with intracranial tumors were treated with Ruta 6X and Calcarea phosphorica (calcium phosphate) 3X (Pathak, Multani, Banerji, 2003). Of the 15 patients, 8 of the 9 glioma patients showed complete regression of tumors; 1 of 3 with meningioma showed complete regression and 2 of 3 showed prolonged arrest; 1 with neurinoma showed prolonged arrest; 1 with craiopharyngioma and 1 with pituitary tumors both showed complete regression.

Providing further verification of the benefits of Ruta graveolens was an animal study (Preethi K, Kuttan G, Kuttan, 2006). An extract of Ruta graveolens was found to be cytotoxic to Dalton's lymphoma ascites (DLA), Ehrlich ascites carcinoma (EAC) and L929 cells in culture (IC100 = 16mg/ml) and also to increase the lifespan of tumour bearing animals. The extract further decreased solid tumours developing from DLA and EAC cells when given simultaneously with elongation of the lifespan of tumour-bearing animals. A homeopathic preparation of Ruta graveolens (200c) was equally effective. Neither was effective for reducing already developed tumours. The Ruta graveolens extract was found to scavenge hydroxyl radicals and inhibit lipid peroxidation at low concentrations. However, at higher concentrations the extract acted as a prooxidant as inhibition of lipid peroxidation and scavenging of hydroxyl radical was minimal. These data indicates that the prooxidant activity of Ruta graveolens may be responsible for the cytocidal action of the extract and its ability to produce tumour reduction.
These researchers also conducted several laboratory experiments in which one or both of these homeopathic medicines showed induction of survival-signaling pathways in normal lymphocytes as well as the induction of death-signaling pathways in brain cancer cells (this means that these medicines improved immune function and increased the body’s ability to kill cancer cells). The researchers also note that one of Ruta’s active ingredients is Rutin, which is know for having anti-oxidant and anti-inflammatory activities and for reducing oxidative damage. The researchers also provide additional detail about the therapeutic benefits from calcium phosphate.

Pathak S, Multani AS, Banerji P, Banerji P., Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer. Int J Oncol. 2003 Oct;23(4):975-82.

Preethi K, Kuttan G, Kuttan R Anti-tumour activity of ruta graveolens extract. Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):439-43.

Haven't looked at the full papers yet and will reserve comment until I have done so. I'll just note in passing that, once again, to suit your convenience you have dropped again concerns about lack of individualisation. Which is it to be, Dana? Do we look at all studies whether individualised or not? If we are to accept non-individualised studies on equal terms then do you drop all objections to considering these studies. That would set you apart from many homeopaths who are very keen to latch onto that as an excuse to reject many negative studies.
 
Last edited:
Here's the first paper;

http://www.virtualtrials.com/pdf/ruta6.pdf

Can't find the full text of the other one at the moment and haven't got time to look at either in detail at the moment. Please could someone have a look. Thanks.

I looked at the part involving treatment of the brain cancer patients. It's not blinded, there are no controls, and there isn't any information given that would allow you to guess what we'd expect to see in the absence of the homeopathic treatment. One cannot conclude that homeopathy had any effect based on that information.

I read through the other parts quickly. The thing that sticks out is that there's no mention of any blinding. It is unsurprising to see that evaluations done by people with a particular result in mind show that result. But you cannot conclude that homeopathy had anything to do with it when the evaluation wasn't blind.

Linda
 

As Linda says, there was no blinding. Apart from that, the trial doesn't seem to be testing homeopathy as it is described by the homeopaths that we encounter on these forums. If there hadn't been any positive result, I'm sure homeopaths would have been quick to dismiss it, for the following reasons:

- The remedies were very low potencies: Ruta 6 (10-12 concentration) in combination with calcium phosphate 3x (10-3 concentration). These are nowhere near the sort of potencies that I see most homeopaths using. Why was no attempt made to test higher potencies (i.e. lower dilutions), that should, according to homeopathic principles, be more powerful?

- Remedies were not individually adjusted to specific patients. This argument is used by many homeopaths (see for example Jeanette Winterson and Denis MacEoin quoted in this thread) to demonstrate that this sort of test is useless, since it doesn't test "real" homeopathy.
 
Certainly it's not really a homeopathic potency. There will certainly be actual mother tincture present, though we have debated the actual likelihood of biologically significant effects at these concentrations.

To be fair to Dana, I did ask for impressive cures and this paper does make such claims. But it falls between two stools. As a research paper there are no controls. As an attempt to present impressive individual cases they are insufficiently documented. In particular the cases were diagnosed "based on radiology and/or
histopathology." That immediately rings alarm bells. The diagnoses were cited in specific histopathological terms. That is not possible if the diagnosis was only made by radiology, whereas the description says "and/or" implying that histology may not have been done for some patients. That's a bit fishy and would have prompted me to question the authors if I had been acting as a scrutineer.
 
In the other thread, DUllman said

And the COPD study...the worst that Orac had to say about it was that the study didn't mention homeopathy in the title of the article and that he was personally shocked that this study made it past the IRB.

Funny that. Cos I thought the worst he had to say about it was:

First, there were only 25 patients in each group, which is a pretty small number for anything other than a pilot study. You have to remember that, when studies are small, spurious results are more likely to occur. At first glance, the patient characteristics in this table appear pretty well balanced. At first glance. Actually, this is a good example of when statistical nonsignificance doesn't necessarily mean clinically nonsignificant. For one thing, the stage of COPD in the control group was higher than that of the treatment group (1.20 ± 0.5 versus 1.08 ± 0.4, p=0.178). This seems very odd, because both groups are listed as having mild COPD by this criteria, given that the COPD stages run from 0 to 3, with 0 being normal lung function and 1 being the least severe. If the average COPD stage for each group was close to 1, then why did the patients have such difficulty coming off the ventilator? Something's odd there, since the mean FEV1 (forced expiratory volume in 1 second) was 54.0 ± 5.3% in the potassium dichromate group and 52.4 ± 5.5% in the control group, both of which are very close to the range of stage 2 COPD (FEV1 between 35% and 49%). In other words, it would seem that most of the patients were bad stage 1 patients.
A more interesting difference, however, and potentially more likely to influence the results of the study comes when you look at the number of patients who were on home oxygen before being hospitalized and developing respiratory failure. In the control group, 9/25 patients were on chronic home oxygen, whereas in the potassium dichromate group, only 5/25 were on home oxygen. Leaving aside that both numbers seem very high for two groups whose COPD scores are 1.2 or below given that it's usually patients with stage 3 COPD who require home oxygen, it is clear that the control group had nearly twice the number of patients who were on home oxygen before admission. This seems inconsistent with a small difference in in the COPD score, and the low COPD scores seem inconsistent with such severe exacerbations. After all, the definition of stage 1 COPD is:
Often minimal shortness of breath with or without cough and/or sputum. Usually goes unrecognized that lung function is abnormal.​
Essentially no patients with stage 1 COPD need home oxygen. Ditto stage 2 COPD, which is defined:
Often moderate or severe shortness of breath on exertion, with or without cough, sputum or dyspnea. Often the first stage at which medical attention is sought due to chronic respiratory symptoms or an exacerbation​
By the measurements listed, the average patient in both groups had at worst slightly worse than stage 1 COPD, which makes it odd indeed that 36% and 20% of the control and potassium dichromate groups, respectively, were on home oxygen. Let's just put it this way. Needing home oxygen is a good marker for one of two things: either more severe COPD or other concurrent lung conditions. Those four extra patients on home oxygen could potentially account for the longer time to extubation and longer length of stay in the hospital in the control group. We can't tell if they do or not because the data isn't presented in such a way to allow us to do so. It's possible that the differences in patients on oxygen before admission made a difference. It's also possible that this is just a spurious result from a relatively small study. Or, it's possible that it might be correct and there might really be an effect, but this latter scenario is unlikely given the flaws in the study and the fact that no homeopath has yet explained a mechanism by which something like homeopathic potassium dichromate might do a single thing to eliminate secretions--or anything else, for that matter.

http://scienceblogs.com/insolence/2007/07/homeopathy_in_thecringeicu_1.php
 
Here's the first paper;

http://www.virtualtrials.com/pdf/ruta6.pdf

Can't find the full text of the other one at the moment and haven't got time to look at either in detail at the moment. Please could someone have a look. Thanks.

Why if this therapy is so successful, has the research not yet been replicated, or the therapy found its way into every oncologists standard armoury? Does Orac know about this paper?

I haven't given the trial any medical scrutiny as yet (a job for Orac?), but I note with interest that the authors run their own Homeopathic Research Foundation in India. They promote the "Banerji Protocol" of therapy, which they freely admit is not classical homeopathy (since there is no individualisation).

Seems like the "Banerji protocol" is a real panacea - read how it cures Dengue fever, Jap B encephalitis, malaria, and dwell on the ramifications of how it cures people who get ill on lunar landings. You see, as they explain, it appears that
the moon has no magnetic field, hence problems of dispersion, solubility, absorption, availability at tissue level, metabolism and excretion of drugs, including recycling problems and disposal, do exist. Thus, in such a state, and in view of the factors referred to above, the use of conventional medicines has its limitations.
It seems that the Banerjis feel this will be useful when the lunar research base is in operation.
:rolleyes:
I wonder if NASA has any inkling that conventional drugs were inneffective in low/zero gravity? Shouldn't someone let them know, in case they actually want to build a lunar base?

PS - found a video link to this research.. Can't view it so no idea if its any use to man or beast. I do see it's over an hour long tho.
 
Last edited:
Certainly it's not really a homeopathic potency. There will certainly be actual mother tincture present, though we have debated the actual likelihood of biologically significant effects at these concentrations.

There's no succussion either, it seems:
Ruta Q, the mother tincture extracted from R. graveolens according to homeopathic pharmacopia, was diluted to Ruta 1 by adding 1 ml of Ruta Q to 99 ml of absolute ethyl alcohol. One milliliter of Ruta 1 when added to 99 ml of alcohol made Ruta 2. Similarly, Ruta 6 was prepared by performing more serial dilutions.

So what chance is there for the homeopathic magic to kick in?
 
Last edited:
I couldn't find anything stating whether or not any of the patients were receiving other treatment. Is this info in there anywhere?
 

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom